Annual Retained Earnings
-$1.60 B
-$51.74 M-3.34%
December 31, 2024
Summary
- As of March 10, 2025, ESPR annual retained earnings is -$1.60 billion, with the most recent change of -$51.74 million (-3.34%) on December 31, 2024.
- During the last 3 years, ESPR annual retained earnings has fallen by -$494.65 million (-44.71%).
- ESPR annual retained earnings is now -12395.35% below its all-time high of -$12.81 million, reached on December 31, 1999.
Performance
ESPR Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.60 B
-$21.32 M-1.35%
December 1, 2024
Summary
- As of March 10, 2025, ESPR quarterly retained earnings is -$1.60 billion, with the most recent change of -$21.32 million (-1.35%) on December 1, 2024.
- Over the past year, ESPR quarterly retained earnings has stayed the same.
- ESPR quarterly retained earnings is now -3714.24% below its all-time high of -$41.98 million, reached on December 31, 2012.
Performance
ESPR Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ESPR Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.3% | 0.0% |
| 3 y3 years | -44.7% | 0.0% |
| 5 y5 years | -130.3% | 0.0% |
ESPR Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.7% | at low | -44.7% | at low |
| 5 y | 5-year | -130.3% | at low | -146.7% | at low |
| alltime | all time | <-9999.0% | at low | -3714.2% | at low |
Esperion Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$1.60 B(+3.3%) | - |
| Dec 2024 | - | -$1.60 B(+1.3%) |
| Sep 2024 | - | -$1.58 B(+1.9%) |
| Jun 2024 | - | -$1.55 B(+4.2%) |
| Mar 2024 | - | -$1.49 B(-3.9%) |
| Dec 2023 | -$1.55 B(+15.6%) | -$1.55 B(+3.8%) |
| Sep 2023 | - | -$1.49 B(+2.8%) |
| Jun 2023 | - | -$1.45 B(+3.6%) |
| Mar 2023 | - | -$1.40 B(+4.6%) |
| Dec 2022 | -$1.34 B(+21.1%) | -$1.34 B(+4.3%) |
| Sep 2022 | - | -$1.28 B(+4.5%) |
| Jun 2022 | - | -$1.23 B(+5.7%) |
| Mar 2022 | - | -$1.16 B(+5.1%) |
| Dec 2021 | -$1.11 B(+31.9%) | -$1.11 B(+6.3%) |
| Sep 2021 | - | -$1.04 B(+7.1%) |
| Jun 2021 | - | -$971.87 M(+4.7%) |
| Mar 2021 | - | -$928.20 M(+10.7%) |
| Dec 2020 | -$838.82 M(+20.6%) | -$838.82 M(+14.2%) |
| Sep 2020 | - | -$734.34 M(+13.2%) |
| Jun 2020 | - | -$648.90 M(-16.1%) |
| Mar 2020 | - | -$773.51 M(+11.3%) |
| Dec 2019 | -$695.27 M(+16.2%) | -$695.27 M(+9.8%) |
| Sep 2019 | - | -$633.32 M(+12.1%) |
| Jun 2019 | - | -$564.94 M(+10.6%) |
| Mar 2019 | - | -$510.72 M(-14.6%) |
| Dec 2018 | -$598.10 M | -$598.10 M(+11.2%) |
| Sep 2018 | - | -$538.06 M(+10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | -$488.15 M(+10.3%) |
| Mar 2018 | - | -$442.42 M(+11.6%) |
| Dec 2017 | -$396.29 M(+72.9%) | -$396.29 M(+10.6%) |
| Sep 2017 | - | -$358.40 M(+14.4%) |
| Jun 2017 | - | -$313.18 M(+16.1%) |
| Mar 2017 | - | -$269.84 M(+17.7%) |
| Dec 2016 | -$229.20 M(+48.6%) | -$229.20 M(+14.5%) |
| Sep 2016 | - | -$200.24 M(+9.5%) |
| Jun 2016 | - | -$182.84 M(+8.3%) |
| Mar 2016 | - | -$168.81 M(+9.5%) |
| Dec 2015 | -$154.22 M(+47.7%) | -$154.22 M(+9.3%) |
| Sep 2015 | - | -$141.10 M(+10.0%) |
| Jun 2015 | - | -$128.30 M(+10.7%) |
| Mar 2015 | - | -$115.90 M(+11.0%) |
| Dec 2014 | -$104.44 M(+53.4%) | -$104.44 M(+10.0%) |
| Sep 2014 | - | -$94.98 M(+11.5%) |
| Jun 2014 | - | -$85.17 M(+12.2%) |
| Mar 2014 | - | -$75.94 M(+11.6%) |
| Dec 2013 | -$68.06 M(+62.2%) | -$68.06 M(+16.6%) |
| Sep 2013 | - | -$58.37 M(+9.9%) |
| Jun 2013 | - | -$53.14 M(+14.7%) |
| Mar 2013 | - | -$46.32 M(+10.4%) |
| Dec 2012 | -$41.98 M(+38.8%) | -$41.98 M |
| Dec 2011 | -$30.23 M(-67.9%) | - |
| Dec 2002 | -$94.05 M(+44.0%) | - |
| Dec 2001 | -$65.32 M(+61.7%) | - |
| Dec 2000 | -$40.39 M(+215.2%) | - |
| Dec 1999 | -$12.81 M | - |
FAQ
- What is Esperion Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Esperion Therapeutics?
- What is Esperion Therapeutics annual retained earnings year-on-year change?
- What is Esperion Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly retained earnings year-on-year change?
What is Esperion Therapeutics annual retained earnings?
The current annual retained earnings of ESPR is -$1.60 B
What is the all time high annual retained earnings for Esperion Therapeutics?
Esperion Therapeutics all-time high annual retained earnings is -$12.81 M
What is Esperion Therapeutics annual retained earnings year-on-year change?
Over the past year, ESPR annual retained earnings has changed by -$51.74 M (-3.34%)
What is Esperion Therapeutics quarterly retained earnings?
The current quarterly retained earnings of ESPR is -$1.60 B
What is the all time high quarterly retained earnings for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly retained earnings is -$41.98 M
What is Esperion Therapeutics quarterly retained earnings year-on-year change?
Over the past year, ESPR quarterly retained earnings has changed by $0.00 (0.00%)